NO962073D0 - Amfifiliske imidazoliniumderivater - Google Patents
Amfifiliske imidazoliniumderivaterInfo
- Publication number
- NO962073D0 NO962073D0 NO962073A NO962073A NO962073D0 NO 962073 D0 NO962073 D0 NO 962073D0 NO 962073 A NO962073 A NO 962073A NO 962073 A NO962073 A NO 962073A NO 962073 D0 NO962073 D0 NO 962073D0
- Authority
- NO
- Norway
- Prior art keywords
- imidazolinium derivatives
- amphiphilic imidazolinium
- amphiphilic
- amphiphiles
- derivatives
- Prior art date
Links
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 239000002502 liposome Substances 0.000 abstract 1
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Lubricants (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15772793A | 1993-11-24 | 1993-11-24 | |
| US08/247,963 US5705655A (en) | 1992-12-17 | 1994-05-24 | Amphiphilic nitrogen containing imidazolinium derivative compounds and uses |
| PCT/US1994/013363 WO1995014380A1 (en) | 1993-11-24 | 1994-11-17 | Amphiphilic imidazolinium derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO962073D0 true NO962073D0 (no) | 1996-05-21 |
| NO962073L NO962073L (no) | 1996-07-09 |
| NO305557B1 NO305557B1 (no) | 1999-06-21 |
Family
ID=26854423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO962073A NO305557B1 (no) | 1993-11-24 | 1996-05-21 | Amfifiliske imidazoliniumderivater og fremgangsmÕte for fremstilling av imidazoliniumion |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5705655A (no) |
| EP (1) | EP0730404B1 (no) |
| JP (1) | JP2918693B2 (no) |
| KR (1) | KR100246839B1 (no) |
| AT (1) | ATE258923T1 (no) |
| AU (1) | AU691217B2 (no) |
| CA (1) | CA2176713C (no) |
| DE (1) | DE69433532T2 (no) |
| NO (1) | NO305557B1 (no) |
| NZ (1) | NZ276645A (no) |
| WO (1) | WO1995014380A1 (no) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5948767A (en) * | 1994-12-09 | 1999-09-07 | Genzyme Corporation | Cationic amphiphile/DNA complexes |
| US5747471A (en) * | 1994-12-09 | 1998-05-05 | Genzyme Corporation | Cationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic molecules |
| US5650096A (en) * | 1994-12-09 | 1997-07-22 | Genzyme Corporation | Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| US5767099A (en) * | 1994-12-09 | 1998-06-16 | Genzyme Corporation | Cationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic molecules |
| US6383814B1 (en) | 1994-12-09 | 2002-05-07 | Genzyme Corporation | Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| US5910487A (en) * | 1994-12-09 | 1999-06-08 | Genzyme Corporation | Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| US5840710A (en) * | 1994-12-09 | 1998-11-24 | Genzyme Corporation | Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules |
| US5719131A (en) * | 1994-12-09 | 1998-02-17 | Genzyme Corporation | Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules |
| US6331524B1 (en) | 1994-12-09 | 2001-12-18 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy |
| US5830878A (en) * | 1995-06-07 | 1998-11-03 | Megabios Corporation | Cationic lipid: DNA complexes for gene targeting |
| US5935936A (en) * | 1996-06-03 | 1999-08-10 | Genzyme Corporation | Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
| US6093816A (en) * | 1996-06-27 | 2000-07-25 | Isis Pharmaceuticals, Inc. | Cationic lipids |
| US5925628A (en) * | 1997-03-31 | 1999-07-20 | Genzyme Corporation | Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| US5912239A (en) * | 1997-04-04 | 1999-06-15 | Genzyme Corporation | Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules |
| US6235310B1 (en) | 1997-04-04 | 2001-05-22 | Valentis, Inc. | Methods of delivery using cationic lipids and helper lipids |
| US5948925A (en) * | 1997-05-06 | 1999-09-07 | Genzyme Corporation | Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids |
| US5952516A (en) * | 1997-05-08 | 1999-09-14 | Genzyme Corporation | Cationic amphiphiles containing multiplesteroid lipophilic groups |
| US5942634A (en) * | 1997-05-09 | 1999-08-24 | Genzyme Corporation | Cationic amphiphiles for cell transfections |
| US6121457A (en) * | 1997-11-14 | 2000-09-19 | Megabios Corporation | Compositions and methods using novel substituted imidazolium lipids |
| US7780882B2 (en) | 1999-02-22 | 2010-08-24 | Georgetown University | Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent |
| US9034329B2 (en) | 1999-02-22 | 2015-05-19 | Georgetown University | Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| ES2366100T3 (es) | 1999-02-22 | 2011-10-17 | Georgetown University | Inmunoliposomas dirigidos mediante un fragmento de anticuerpo para la administración sistémica de genes. |
| WO2002078608A2 (en) * | 2001-04-02 | 2002-10-10 | Georgetown University | A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| US7297712B2 (en) * | 2002-03-27 | 2007-11-20 | Council Of Scientific And Industrial Research | Cationic amphiphiles for intracellular delivery of therapeutic molecules and its composition, process and method of treatment |
| AU2007257357B2 (en) | 2006-05-15 | 2010-08-26 | Georgetown University | Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| US8044215B2 (en) * | 2009-04-29 | 2011-10-25 | Juvaris Biotherapeutics, Inc. | Methods for the preparation of amphillic nitrogen containing imidazolinium derivative compounds |
| GB2578557B (en) | 2013-07-16 | 2020-09-02 | Univ Leland Stanford Junior | Enhancement of osteogenic potential of bone grafts |
| ES2901788T3 (es) * | 2015-05-04 | 2022-03-23 | Bayer Animal Health Gmbh | Proceso para la preparación de compuestos anfifílicos de imidiazolinio |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2945821A (en) * | 1956-10-24 | 1960-07-19 | Nalco Chemical Co | Process of inhibiting corrosion |
| US3186912A (en) * | 1959-08-03 | 1965-06-01 | Robert L Beamer | Cosmetic emulsion |
| US3210312A (en) * | 1961-07-25 | 1965-10-05 | Geigy Chem Corp | Anti-electrostatic imidazoline salts for resin compositions |
| NL281319A (no) * | 1961-07-25 | |||
| US3205092A (en) * | 1962-02-20 | 1965-09-07 | Geigy Chem Corp | Magnetic tape having improved antistatic properties |
| US3216957A (en) * | 1962-08-14 | 1965-11-09 | Union Carbide Corp | Antistatic thermoplastic vinyl resin compositions comprising oxyalkylated imidazolines |
| US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
-
1994
- 1994-05-24 US US08/247,963 patent/US5705655A/en not_active Expired - Lifetime
- 1994-11-17 JP JP7515155A patent/JP2918693B2/ja not_active Expired - Lifetime
- 1994-11-17 WO PCT/US1994/013363 patent/WO1995014380A1/en active IP Right Grant
- 1994-11-17 CA CA002176713A patent/CA2176713C/en not_active Expired - Lifetime
- 1994-11-17 AT AT95901947T patent/ATE258923T1/de not_active IP Right Cessation
- 1994-11-17 NZ NZ276645A patent/NZ276645A/en unknown
- 1994-11-17 KR KR1019960702744A patent/KR100246839B1/ko not_active IP Right Cessation
- 1994-11-17 DE DE69433532T patent/DE69433532T2/de not_active Expired - Lifetime
- 1994-11-17 EP EP95901947A patent/EP0730404B1/en not_active Expired - Lifetime
- 1994-11-17 AU AU10999/95A patent/AU691217B2/en not_active Ceased
-
1996
- 1996-05-21 NO NO962073A patent/NO305557B1/no not_active IP Right Cessation
-
1997
- 1997-05-19 US US08/858,571 patent/US5736395A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69433532D1 (de) | 2004-03-11 |
| CA2176713A1 (en) | 1995-06-01 |
| JPH09505594A (ja) | 1997-06-03 |
| AU691217B2 (en) | 1998-05-14 |
| US5705655A (en) | 1998-01-06 |
| WO1995014380A1 (en) | 1995-06-01 |
| DE69433532T2 (de) | 2005-01-05 |
| EP0730404B1 (en) | 2004-02-04 |
| ATE258923T1 (de) | 2004-02-15 |
| US5736395A (en) | 1998-04-07 |
| AU1099995A (en) | 1995-06-13 |
| NZ276645A (en) | 1998-05-27 |
| NO962073L (no) | 1996-07-09 |
| KR100246839B1 (ko) | 2000-08-01 |
| EP0730404A4 (en) | 1997-02-19 |
| JP2918693B2 (ja) | 1999-07-12 |
| NO305557B1 (no) | 1999-06-21 |
| CA2176713C (en) | 2000-02-22 |
| EP0730404A1 (en) | 1996-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO962073L (no) | Amfifiliske imidazoliniumderivater | |
| ES552627A0 (es) | Procedimiento para la preparacion de carbamatos de fenilo | |
| DK0758248T3 (da) | Formuleringer til faktor IX | |
| MY107158A (en) | 3-arylcarbonyl; -1h-indoles useful as therapeutic agents. | |
| NO2004004I2 (no) | Bortezomib eller en farmasøytisk akseptabel ester derav, eventuelt i form av et farmasøytisk akseptabelt salt derav | |
| ATE22562T1 (de) | 6-substituierte s-triazolo(3,4-a)phthalazinderivate. | |
| NL980012I2 (nl) | Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen. | |
| NO962074L (no) | Amfifiliske derivater av guanidin | |
| MX9302116A (es) | Compuestos azabiciclo. | |
| NO951283D0 (no) | Nye taxanderivater, deres fremstilling samt farmasöytiske preparater inneholdende derivatene | |
| MY128260A (en) | Cyclopentane-and-pentene-b-amino acids | |
| ES2174113T3 (es) | Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales. | |
| MX9400165A (es) | Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen. | |
| ES2141978T3 (es) | Retinoides triciclicos, metodos para su produccion y uso. | |
| DE69431662T2 (de) | Stabilisierte tablettenformulierung | |
| NO923266L (no) | Heksahydrobenzo(f)quinolinoner | |
| FR2622104B1 (fr) | Procede de stabilisation de phases lamellaires lipidiques hydratees, par ex. de liposomes, composition de phases lamellaires lipidiques hydratees, par ex. des liposomes, stabilisees par un emploi d'un support stabilisant a base d'atelocollagene et de glycosaminoglycannes et utilisation en pharmacie ou en cosmetologie | |
| NO932502D0 (no) | Nye fosfolipidderivater | |
| KR970006264A (ko) | 신규한 6-치환-5, 8-디옥시-1, 4-나프토퀴논 유도체, 그의 제조방법 및 그의 항암제로서의 용도 | |
| MX9206365A (es) | Tetrahidrobenzotienopiridinas,proceso para su preparacion y composicion farmaceutica que las contiene | |
| FI945414A0 (fi) | Menetelmä N,N-disubstituoidun aminofenolin valmistamiseksi | |
| ES474052A1 (es) | Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas. | |
| DE69215511D1 (de) | Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen | |
| ES2187963T3 (es) | Sales farmaceuticamente aceptables de 3-sulfato de 3-hidroxi-estr-5(10)-en 17-ona activas con estrogenos. | |
| GR1001497B (el) | Οπτικώς δραστικά ισοϊνδολινο παράγωγα, η παραγωγή και η χρησιμοποίηση αυτών. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN MAY 2003 |